Navigation Links
Efficient Cellular Fractionation for RNA ,,, and Protein Isolation

Efficient Cellular Fractionation for RNA and Protein Isolation


Ambion's Protein and RNA Isolation System, PARIS, uses a rapid and simple procedure to isolate both total RNA and native protein from the same experimental sample. Cultured cells and tissues that are either fresh, frozen, or treated with RNA stabilization reagents such as RNAlater and RNAlater-ICE, are all compatible with the procedure. This kit provides a unique tool for researchers who need both RNA and protein for various downstream analysis, reducing time, cost, and variability between independent experimental samples. The PARIS Kit also permits separation of nuclear and cytoplasmic fractions from fresh cultured cells prior to RNA and/or protein isolation. Here, we tested the procedure with various mammalian cell types and show that both RNA and native protein are efficiently recovered from nuclear and cytoplasmic fractions with virtually no cross contamination between the two cellular compartments.


Fast and Simple Cellular Fractionation
To obtain total cellular protein and RNA using the PARIS Kit, whole cells are first homogenized in ice-cold Cell Disruption Buffer to prepare a total cell lysate. Since the homogenization is performed quickly on ice and in the presence of detergent, both protein and high quality RNA can be isolated from this lysate. For RNA isolation, a part of the tota
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Efficiently Insert Unique Restriction Sites into Plasmid Vectors
2. Efficient Cleavage of Fusion Proteins to Yield Native Amino Termini
3. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
4. Efficient Transfection of Neurospora Crassa
5. Efficient Transfection of Neurospora Crassa
6. Efficient Recovery of Ultrapure Plasmid DNA
7. Efficient and Reliable PCR Setup Using Eppendorf MasterMix
8. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
9. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
10. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
11. Efficient and Reliable Linear Amplification of cRNA
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Efficient Cellular Fractionation for RNA and Protein Isolation

(Date:10/15/2008)... DUSSELDORF, Germany, October 15 /PRNewswire-First... to EUR268.0m, - Adjusted Group Results More Than... to EUR16.5m, - Sales Process Started for Technic...irms the Outlook for 2008, Gerresheimer AG again ...ting results in the third quarter of 2008. Overall...
(Date:10/14/2008)...PRESS RELEASE , 13 October 2008] Recent research f...itutet reveals completely new properties of the sk...ous findings. The studies, which are published in ... hair follicle stem cells can divide actively and ... "The stem cells don,t behave at all in the way w...
(Date:10/14/2008)... MOUNTAIN VIEW, Calif., Oct. 14 /- Ba...ket, Frost & Sullivan recognizes ISTO,Technologies...an Award for,Product Innovation for its novel InQu...nQu represents the first commercial product launch...l-based platform technology., Although spinal fus...
(Date:10/14/2008)... - Conference Call to Discuss Results to Be Hel...-FirstCall/ -- ViroPharma Incorporated,s,(Nasdaq: ...re expected to be,released on Wednesday, October 2...ets., The company will host a conference call and...he same day. During the conference call, ViroPharm...
Breaking Biology Technology:Gerresheimer Substantially Increases Quarterly Operating Profit 2Gerresheimer Substantially Increases Quarterly Operating Profit 3Gerresheimer Substantially Increases Quarterly Operating Profit 4Gerresheimer Substantially Increases Quarterly Operating Profit 5Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing 2Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing 3Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing 4ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008 2
...wrote a column criticizing an "advice article" in ...wo-week notices when leaving a company. ( Ready t... ) It was published both on ePrairie and with the ...copy was left up for comments. Since then, there h...ple leaving jobs. , ,According to WTN,s editor, it...
...rus Bio Corporation says its scientists have deve...aply. , ,Antibodies, naturally part of the immune ... diseases and for diagnostics or research. Mirus, ...BioTechniques, involves intravenously injecting DN...ntibodies that are harvested and used. , ,Accordin...
...sh; Inacom Information Systems was awarded Cisco...working company,s annual partner summit in San Die... Wireless Makeover marketing campaign, which the c...and one, Dane Manufacturing, to be given an implem...egan last November, and Inacom will hold a seminar...
...is. Cyber Defense Agency, an information securit...in several other states, said it has been chosen t...urity contest. , ,"Cyber attacks are increasing in...to support collegiate cyber competitions that will...s," said Sami Saydjari, president and founder of t...
Other Biology Technology:Employees debate ethics of giving two weeks' notice 2Employees debate ethics of giving two weeks' notice 3Employees debate ethics of giving two weeks' notice 4Employees debate ethics of giving two weeks' notice 5
(Date:10/14/2008)...Scientists at the University of Idaho currently ar... known to have been running rampant for the past d... FBI,s Most Wanted list. Instead, it,s on the mind..., Its name is Batrachochytrium dendrobatidis (B..., a type of protein found in the skin of amphibian...
(Date:10/14/2008)...14, 2008) -- In the last decade, biomedical and re... cells, have helped transform the care of children...iseases. On Nov. 8 and 9, Morgan Stanley Children,...iversity Medical Center will host a conference at ...ediatric Medicine," to exchange the latest advance...
(Date:10/14/2008)...lease is available in Spanish . , An interdisc...alt at the Institute for Research in Biomedicine (...tut Catal d,Investigaci Qumica" (ICIQ, Tarragona),...maintain protein p53 stable even when it presents ...ancer. Giralt, head of the Chemistry and Molecular...
(Date:10/14/2008)....--Genetically modifying a receptor found on the n...has given California Institute of Technology (Calt...s of the brain,s dopamine system--as well as a new...her too much or too little of this critical neurot...ren Professor of Biology, and Ryan Drenan, senior ...
Breaking Biology News(10 mins):Modern genetics vs. ancient frog-killing fungus 2Modern genetics vs. ancient frog-killing fungus 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 2Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 4Design of a compound that stabilizes the main natural suppressor of tumors 2Caltech scientists engineer supersensitive receptor, gain better understanding of dopamine system 2MacroChem Announces Preferred Stock Conversions and 243 5 Million Private Placement 3309 1MacroChem Announces Preferred Stock Conversions and 243 5 Million Private Placement 3309 2MacroChem Announces Preferred Stock Conversions and 243 5 Million Private Placement 3309 3Bellicum Pharmaceuticals Announces 243 75 Million in Financing 3307 1Bellicum Pharmaceuticals Announces 243 75 Million in Financing 3307 2Bellicum Pharmaceuticals Announces 243 75 Million in Financing 3307 3Buck Consultants Reports Wellness Programs Are Truly Global 3B Objectives Vary by Region 3305 1Buck Consultants Reports Wellness Programs Are Truly Global 3B Objectives Vary by Region 3305 2Buck Consultants Reports Wellness Programs Are Truly Global 3B Objectives Vary by Region 3305 3Buck Consultants Reports Wellness Programs Are Truly Global 3B Objectives Vary by Region 3305 4Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 1Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 2Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 3Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 4Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 5Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 6Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 7Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 8Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 9Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 10Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 11Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 12Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 13Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 14Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 15Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 16Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 17Monsanto Sees Record Sales in Fiscal Year 2007 3B Seeds and Traits Business Contributes to Strong Fourth Quarter and Year End Results 1177 18
...the New York-based Wildlife Conservation Society, ...s a cost-effective means of keeping potential dead...ring. The study appears in the July edition of the... controlling the spread of diseases afflicting bot...s of billions of dollars globally. , "Few threats ...
...citrus greening (huanglongbing) in samples collect...reat to Florida,s $9 billion commercial citrus ind...ds are needed to reduce the amount of crop loss ca...The American Phytopathological Society (APS). Citr...e phloem system of citrus plants causing the infec...
...uldn,t care less because they can,t digest it. A n...rily people whose ancestors came from places where...ly, such as in Europe, who have developed the abil...ts whose ancestors lived in very hot or very cold ... places where deadly diseases of cattle were prese...
...the anticoagulant drug warfarin to prevent harmful...urgery. But the proper dose of warfarin can vary g...riability may boil down to a recently identified g... study published in the June 2 issue of The New En...etic makeup of people on warfarin, researchers at ...
Other Biology News:Controlling wildlife trade key to preventing health crises, study says 2Lactose intolerance linked to ancestral environment 2Lactose intolerance linked to ancestral environment 3Genetic variation alters response to common anti-clotting drug 2Genetic variation alters response to common anti-clotting drug 3
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA.
Peptide sequences: Two separate vials containing 200 g of peptide corresponding to the same sequence used as antigens for guanylate cyclase polyclonal antiserum (Catalog No. 160890) To be used i
Expansion and Cryopreservation of Cells from Meridian Life Science, Inc.
Medium for cryopreserving subcutaneous or omental preadipocytes
Biology Products: